JP4740883B2 - ピペリジニルプロスタグランジンｅ類似体 - Google Patents

ピペリジニルプロスタグランジンｅ類似体 Download PDF

Info

Publication number
JP4740883B2
JP4740883B2 JP2006551189A JP2006551189A JP4740883B2 JP 4740883 B2 JP4740883 B2 JP 4740883B2 JP 2006551189 A JP2006551189 A JP 2006551189A JP 2006551189 A JP2006551189 A JP 2006551189A JP 4740883 B2 JP4740883 B2 JP 4740883B2
Authority
JP
Japan
Prior art keywords
oxo
piperidin
acetic acid
phenyl
enyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006551189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007520489A5 (enExample
JP2007520489A (ja
Inventor
デイビッド・ダブリュー・オールド
ダニー・ティ・ディン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of JP2007520489A publication Critical patent/JP2007520489A/ja
Publication of JP2007520489A5 publication Critical patent/JP2007520489A5/ja
Application granted granted Critical
Publication of JP4740883B2 publication Critical patent/JP4740883B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2006551189A 2004-01-22 2005-01-14 ピペリジニルプロスタグランジンｅ類似体 Expired - Fee Related JP4740883B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/763,702 2004-01-22
US10/763,702 US6977260B2 (en) 2004-01-22 2004-01-22 Piperidinyl prostaglandin E analogs
PCT/US2005/001461 WO2005072735A1 (en) 2004-01-22 2005-01-14 Piperidinyl prostaglandin e analogs

Publications (3)

Publication Number Publication Date
JP2007520489A JP2007520489A (ja) 2007-07-26
JP2007520489A5 JP2007520489A5 (enExample) 2008-02-28
JP4740883B2 true JP4740883B2 (ja) 2011-08-03

Family

ID=34795110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551189A Expired - Fee Related JP4740883B2 (ja) 2004-01-22 2005-01-14 ピペリジニルプロスタグランジンｅ類似体

Country Status (11)

Country Link
US (1) US6977260B2 (enExample)
EP (1) EP1722795B1 (enExample)
JP (1) JP4740883B2 (enExample)
AR (1) AR047436A1 (enExample)
AT (1) ATE394101T1 (enExample)
AU (1) AU2005209209B2 (enExample)
CA (1) CA2553387C (enExample)
DE (1) DE602005006534D1 (enExample)
ES (1) ES2303672T3 (enExample)
TW (1) TWI348370B (enExample)
WO (1) WO2005072735A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326716B2 (en) * 2003-06-06 2008-02-05 Allergan, Inc. Treatment of inflammatory bowel disease
WO2006047466A2 (en) * 2004-10-21 2006-05-04 Duke University Ophthamological drugs
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3220156C2 (de) * 1982-05-28 1990-01-25 Heida Houston Tex. Thurlow Mit Metallgriffen, insbesondere Edelstahlgriffen, versehenes Koch- und Bratgeschirr mit Deckel
IT1225716B (it) * 1988-10-26 1990-11-22 Esacontrol Spa Dispositivo per la protezione dei rele' di binario dai disturbi elettrici
CA2021316C (en) 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5034413A (en) 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
US4994274A (en) 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5028624A (en) 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
DE4318713C1 (de) * 1993-06-07 1994-09-15 Daimler Benz Ag Zahnräderwechselgetriebe der Vorgelegebauart
JP4766875B2 (ja) * 2002-06-06 2011-09-07 メルク フロスト カナダ リミテツド Ｅｐ４受容体作動薬、組成物及びその方法
US7053085B2 (en) 2003-03-26 2006-05-30 Merck & Co. Inc. EP4 receptor agonist, compositions and methods thereof
WO2004063158A1 (en) 2003-01-10 2004-07-29 F.Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists
US6747037B1 (en) * 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
WO2004108215A1 (en) * 2003-06-06 2004-12-16 Allergan, Inc. Piperidinyl prostaglandin e analogs

Also Published As

Publication number Publication date
ATE394101T1 (de) 2008-05-15
HK1099203A1 (en) 2007-08-10
AU2005209209B2 (en) 2012-03-08
ES2303672T3 (es) 2008-08-16
EP1722795A1 (en) 2006-11-22
AU2005209209A1 (en) 2005-08-11
WO2005072735A1 (en) 2005-08-11
US6977260B2 (en) 2005-12-20
TWI348370B (en) 2011-09-11
CA2553387A1 (en) 2005-08-11
TW200533350A (en) 2005-10-16
EP1722795B1 (en) 2008-05-07
AR047436A1 (es) 2006-01-18
US20050164990A1 (en) 2005-07-28
JP2007520489A (ja) 2007-07-26
DE602005006534D1 (de) 2008-06-19
CA2553387C (en) 2013-04-02

Similar Documents

Publication Publication Date Title
US6747037B1 (en) Piperidinyl prostaglandin E analogs
EP1503984B1 (en) 8-azaprostaglandin analogs as agents for lowering intraocular pressure
JP5579658B2 (ja) ピペリジニルプロスタグランジンｅ類似体
JP4740883B2 (ja) ピペリジニルプロスタグランジンｅ類似体
JP4520738B2 (ja) 眼圧降下剤としての３、７、または３および７チアまたはオキサプロスタン酸誘導体
EP1631355B1 (en) Piperidinyl prostaglandin e analogs
JP2006526638A (ja) 眼圧降下剤としての３−オキサ−８−アザプロスタグランジン類似体
JP2006526637A (ja) 医薬としての８−アザプロスタグランジンカーボネートおよびチオカーボネート類似体
AU2011202937B2 (en) 8-azaprostaglandin analogs as agents for lowering intraocular pressure
HK1099203B (en) Piperidinyl prostaglandin e analogs
HK1072603B (en) 8-azaprostaglandin analogs as agents for lowering intraocular pressure

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20071225

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20071225

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080108

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20080108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080111

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080111

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110331

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110502

R150 Certificate of patent or registration of utility model

Ref document number: 4740883

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140513

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees